A tale of two alleles: TP53 and transformation in MPNs

A tale of two alleles: TP53 and transformation in MPNs

Bibliographic Details
Main Authors:	Brierley, C, Psaila, B
Format:	Journal article
Language:	English
Published:	American Society of Hematology 2022

Similar Items

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
by: Davidson Zhao, et al.
Published: (2023-03-01)

MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives
by: Hans Carl Hasselbalch, et al.
Published: (2015-01-01)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
by: Melania Tesio
Published: (2023-02-01)

Philadelphia Negative MPNs, MDS/MPNs and MDS in the Context of Recent WHO Changes and Inclusion of Molecular Signatures into Prognostic Tools: A Single Centre Experience
by: Neha Singh, et al.
Published: (2023-01-01)

Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
by: Hans C. Hasselbalch
Published: (2020-06-01)

Magnetic Peripheral Nerve Stimulation (mPNS) for Chronic Pain
by: Bedder M, et al.
Published: (2023-07-01)

Menstrual Practice Needs Scale short form (MPNS-SF) and rapid (MPNS-R): development in Khulna, Bangladesh, and validation in cross-sectional surveys from Bangladesh and Uganda
by: Md Tanvir Hasan, et al.
Published: (2024-07-01)

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
by: Bernard, E, et al.
Published: (2020)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
by: Haiwei Wang, et al.
Published: (2022-06-01)

P066: Variant overlooked: A partial deficiency TP53 allele that skirts interpretation criteria
by: Lisa Lansdon, et al.
Published: (2023-01-01)

Recent Advances of Fe(III)/Fe(II)-MPNs in Biomedical Applications
by: Weipeng Chen, et al.
Published: (2023-04-01)

The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
by: Dmitriy Sonkin
Published: (2015-10-01)

Investigating molecular vulnerabilities in TP53-mutant transformed myeloproliferative neoplasms
by: Paterson, A
Published: (2024)

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms
by: Mithun Vinod Shah, et al.
Published: (2023-04-01)

Progress of TP53 Family Gene TP73 and Tumorigenesis
by: XU Jie, et al.
Published: (2021-02-01)

TP53 immunohistochemistry correlates with TP53 mutation status and clearance in decitabine-treated patients with myeloid malignancies
by: Marianna B. Ruzinova, et al.
Published: (2019-08-01)

TP53 Pro72 allele is enriched in oral tongue cancer and frequently mutated in esophageal cancer in India.
by: Raju S R Adduri, et al.
Published: (2014-01-01)

Correction Notice: Cytokine Profiling as a Novel Complementary Tool to Predict Prognosis in MPNs?
Published: (2020-10-01)

A JAK of all trades: how global phosphoproteomics reveal the Achilles heel of MPNs
by: Tina M. Schnoeder, et al.
Published: (2021-03-01)

The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers
by: Magali Olivier, et al.
Published: (2007-02-01)

A patient with multiple primary malignant neoplasms with high variant allele frequencies of RB1, TP53, and TERT
by: Mingyang Ma, et al.
Published: (2024-02-01)

Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
by: Keith R Loeb, et al.
Published: (2012-01-01)

Essential thrombocytosis transformed AML with TP53 mutations and its clinical implications
by: Yang Si, et al.
Published: (2024-12-01)

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms
by: Ellen C. Moore, et al.
Published: (2018-07-01)

Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the <i>MPL</i> Gene: Two Case Reports
by: Maria Stella Pennisi, et al.
Published: (2023-05-01)

Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development.
by: Morten Andersen, et al.
Published: (2017-01-01)

TP53 PATHOGENIC VARIANTS RELATED TO CANCER
by: Rosero C.Y., et al.
Published: (2019-12-01)

<it>TP73 </it>allelic expression in human brain and allele frequencies in Alzheimer's disease
by: Vonsattel Jean-Paul, et al.
Published: (2004-06-01)

Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
by: Xuerui Li, et al.
Published: (2020-07-01)

Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution
by: Rodriguez-Meira, A, et al.
Published: (2023)

Machine learning analysis of gene expression reveals TP53 Mutant-like AML with wild type TP53 and poor prognosis
by: Yoonkyu Lee, et al.
Published: (2024-05-01)

Convergent TP53 loss and evolvability in cancer
by: Marcela Braga Mansur, et al.
Published: (2023-09-01)

KRAS and TP53 mutations in colorectal carcinoma
by: Al-Kuraya Khawla
Published: (2009-01-01)

Utility of TP53 in Breast Carcinoma Immunophenotypes
by: Ria Jaggi, et al.
Published: (2020-09-01)

Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians
by: Andrzej Dmytrzak, et al.
Published: (2019-01-01)

The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma
by: Sharmilan Thanendrarajan, et al.
Published: (2017-09-01)

Transglutaminase 2 contributes to a TP53-induced autophagy program to prevent oncogenic transformation
by: Shi Yun Yeo, et al.
Published: (2016-03-01)

AVALIAÇÃO FUNCIONAL DA VIA TP53/TP73 NA LEUCEMIA MIELOIDE AGUDA
by: DA Pereira-Martins, et al.
Published: (2023-10-01)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022-01-01)